Travel and Flight Restriction
02 Dec 2021
| Total Cases | 606,633 |
| New Cases |
135
|
| New Cases (per 1 million citizens) | 101.6 |
| Transmission Rate | n/a |
| COVID-19 Hazard & Exposure | 2.3 |
| Socio-Economic Vulnerability | 0.7 |
| Health Conditions | 0.8 |
| Access to Health Care | 1.8 |
| Infrastructure | 1.8 |
| Lack of Coping Capacity (Hazard-Independent) | 2.2 |
| Lack of Coping Capacity | 2.4 |
| COVID-19 Lack of Coping Capacity | 2.6 |
| COVID-19 Risk | 3 |
| COVID-19 Risk Class | Low |
| Rank | 161 |
| COVID-19 Total Vaccination | 2,070,596 |
| COVID-19 Daily Vaccination | 737 |
| COVID-19 Vacc. (per 100 citizens) | 156.15 |
| COVID-19 Daily Vacc. (per 1 million citizens) | 556 |
| Date | Vaccine | Total Vaccinated |
|---|---|---|
| 14 Oct 2022 | Pfizer/BioNTech | 1,592,540 |
| 14 Oct 2022 | Moderna | 241,105 |
| 14 Oct 2022 | Johnson&Johnson | 78,993 |
| 14 Oct 2022 | Novavax | 2,130 |
| Air Transport, Passengers Carried | 1.3 |
| Point of Entry | 4 |
| Access to Cities | 3.2 |
| Mobile Cellular Subscriptions (per 100 people) | 2.8 |
| Internet Users | 1.3 |
| COVID-19 Vulnerability | 7 |
| Drinking Water | 0 |
| COVID-19 Hazard & Exposure | 2.3 |
| Population Living in Slums | n/a |
| Corruption Perception Index | 2.6 |
| Hospital Bed | 3.8 |
| Health System Capacity | 2.55 |
| Immunization Coverage | 1.2 |
| Health Capacity Specific to COVID-19 | 2.6 |
| COVID-19 Lack of Coping Capacity | 2.6 |
| Human Development Index | 0.88 |
| Incidence of Tuberculosis (per 10,000 people) | 15 |
| Malaria Incidence (per 1,000 people) | No data |
| Estimated Number of People Living With HIV (%) | 1.3 |
| Air Transport, Passengers Carried | 31,981 |
| Mobile Cellular Subscriptions (per 100 people) | 145.44 |
| Total Population | 1,325,649 |
| Land area (sq. km) | 42,390 |
| Year | Type | Total Affected | Total Deaths |
|---|---|---|---|
| 2018 | Extreme temperature / Cold wave | 7 |